Skip to content
Inciteful Med

Subtypes and Severity: Mapping Your Genetic Profile

Published: | Updated:

Alpha-thalassemia severity depends on how many of your four alpha-globin genes are missing or broken. Subtypes range from asymptomatic silent carriers and mild traits to more severe conditions like Hemoglobin H disease and Hb Bart syndrome.

Key Takeaways

  • • Alpha-thalassemia has four main subtypes determined by how many of your four alpha-globin genes are missing or damaged.
  • • Silent carriers and people with the alpha-thalassemia trait typically experience no symptoms or only mild fatigue.
  • • Hemoglobin H (HbH) disease involves three missing genes and causes moderate to severe anemia requiring clinical management.
  • • Whether you have a 'cis' or 'trans' trait significantly affects the risk of passing a severe form of the disorder to your children.
  • • Non-deletional mutations, where a gene is present but broken, often cause more severe symptoms than typical missing gene deletions.

The severity of alpha-thalassemia is determined by a simple mathematical relationship: the fewer working alpha-globin genes you have, the more severe the condition [1][2]. Because every person normally has four of these genes, the condition is categorized into four distinct subtypes based on how many of those genes are missing or damaged [1][3].

The Four Subtypes of Alpha-Thalassemia

1. Silent Carrier (1 Gene Deletion)

In this state, one alpha-globin gene is missing or non-functional, leaving you with three working genes [1].

  • Symptoms: None. You are clinically healthy and your standard blood tests (like hemoglobin) usually appear normal [1].
  • Diagnosis: Often only discovered through specialized DNA testing, usually when a parent or child is diagnosed with a more severe form [1].

2. Alpha-Thalassemia Trait (2 Gene Deletions)

Also called “Alpha-Thal Minor,” this occurs when two genes are missing, leaving you with two working genes [1][4].

  • Symptoms: Most people are asymptomatic or have very mild anemia (fatigue) [4].
  • Blood Work: Your red blood cells will be smaller (microcytic) and paler (hypochromic) than average [5][6].

3. Hemoglobin H (HbH) Disease (3 Gene Deletions)

With only one working gene remaining, your body struggles to produce enough alpha-globin [1][4].

  • Symptoms: Moderate to severe anemia, fatigue, and potential jaundice (yellowing of the skin/eyes).
  • Management: This is considered a clinical disease state. While many do not need regular transfusions, anemia can worsen during infections or pregnancy [4][5].

4. Hb Bart Syndrome (4 Gene Deletions)

This is the most severe form, where all four alpha-globin genes are missing [7].

  • Impact: Because no alpha-globin is produced, the fetus cannot carry oxygen effectively [7].
  • Outlook: Historically, this was always fatal before or shortly after birth. Today, some babies survive through intrauterine transfusions (transfusions given before birth) and long-term specialized care [8][9].

The “Cis” vs. “Trans” Difference

If you have the Alpha-Thalassemia Trait (2 gene deletions), the way those genes are missing matters immensely for your family planning.

Type Description Common Ancestry Reproductive Risk
Trans (-α/-α) One gene is missing from each chromosome [10]. Often seen in people of African or Mediterranean descent [11]. You cannot pass on two deletions on one chromosome to a child [12].
Cis (–/αα) Both missing genes are on the same chromosome [10]. Frequently seen in people of Southeast Asian descent [11]. If your partner also has a ‘cis’ deletion, there is a 25% risk for the child to have Hb Bart syndrome [11][10].

Deletional vs. Non-Deletional Types

Most cases of alpha-thalassemia are caused by “deletions” (where the gene is physically missing) [1]. However, some people have “non-deletional” mutations, where the gene is present but broken (such as Hb Constant Spring) [2][13]. Generally, non-deletional types result in more severe symptoms and a higher risk of complications than the deletional types with the same number of affected genes [5][13]. DNA testing is the only way to distinguish these differences [14].

Frequently Asked Questions

What is an alpha-thalassemia silent carrier?
A silent carrier is missing one of the four alpha-globin genes. People with this subtype are clinically healthy, have normal standard blood tests, and usually only discover their status through specialized DNA testing.
What is the difference between alpha-thalassemia cis and trans deletions?
In the 'trans' type, one gene is missing from each chromosome, which limits the risk of passing severe disease to a child. In the 'cis' type, both missing genes are on the same chromosome, which increases the reproductive risk of having a child with a severe subtype.
What are the symptoms of Hemoglobin H (HbH) disease?
Hemoglobin H disease occurs when three alpha-globin genes are missing. It typically causes moderate to severe anemia, fatigue, and sometimes jaundice, and symptoms can worsen during infections or pregnancy.
What does it mean to have a non-deletional alpha-thalassemia mutation?
A non-deletional mutation means the alpha-globin gene is physically present but broken or dysfunctional. These types generally cause more severe symptoms and complications compared to standard deletional types.

Questions for Your Doctor

  • • Can you explain my specific genotype (e.g., --SEA or -α/3.7) and how it affects my symptoms?
  • • If I have HbH disease, is it the 'deletional' or 'non-deletional' type, and does that change my care plan?
  • • Does my subtype put me at risk for iron overload even if I don't receive transfusions?
  • • Should I be monitored by a hematologist who specializes in hemoglobin disorders?

Questions for You

  • • Have I ever been tested for the specific DNA mutations that cause alpha-thalassemia, or was my diagnosis based only on standard blood counts?
  • • Does my ethnic background (such as Southeast Asian, Mediterranean, or African) influence which subtype is most likely for me?
  • • If I have siblings or children, have they been screened for their carrier status?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Clinical practice guidelines for alpha-thalassemia].

    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association , Shang X, Zhang X, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(3)):235-242 doi:10.3760/cma.j.issn.1003-9406.2020.03.003.

    PMID: 32128738
  2. 2

    Analysis of Hematological Parameters in Relation to Genotypes in 497 Patients with Hemoglobin H Disease.

    Lan L, Zheng Z, Wu H

    International journal of general medicine 2025; (18()):7547-7557 doi:10.2147/IJGM.S567328.

    PMID: 41424969
  3. 3

    Rapid detection of α-thalassaemia alleles of --(SEA)/, -α(3.7)/ and -α(4.2)/ using a dual labelling, self-quenching hybridization probe/melting curve analysis.

    Gao L, Liu Y, Sun M, et al.

    Molecular and cellular probes 2015; (29(6)):438-441 doi:10.1016/j.mcp.2015.07.004.

    PMID: 26190814
  4. 4

    The Clinical Phenotypes of Alpha Thalassemia.

    Lal A, Vichinsky E

    Hematology/oncology clinics of North America 2023; (37(2)):327-339 doi:10.1016/j.hoc.2022.12.004.

    PMID: 36907606
  5. 5

    Investigation of the Influence of Deletional and Non-Deletional Hemoglobin H Disease on Pregnancy Outcomes.

    Zhao KS, Pan QA, Yang HY, et al.

    International journal of women's health 2025; (17()):1-7 doi:10.2147/IJWH.S497671.

    PMID: 39802921
  6. 6

    Molecular and Haematological Characteristics of alpha-Thalassemia Deletions in Yogyakarta Special Region, Indonesia.

    Husna N, Handayani NSN

    Reports of biochemistry & molecular biology 2021; (10(3)):346-353 doi:10.52547/rbmb.10.3.346.

    PMID: 34981010
  7. 7

    Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.

    Amid A, Chen S, Athale U, et al.

    Haematologica 2018; (103(5)):e184-e187 doi:10.3324/haematol.2017.178368.

    PMID: 29371322
  8. 8

    Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis.

    Amid A, Chen S, Brien W, et al.

    Blood 2016; (127(9)):1208-11 doi:10.1182/blood-2015-10-673889.

    PMID: 26732098
  9. 9

    Outcomes and morbidities of patients who survive haemoglobin Bart's hydrops fetalis syndrome: 20-year retrospective review.

    Chan WY, Leung AW, Luk CW, et al.

    Hong Kong medical journal = Xianggang yi xue za zhi 2018; (24(2)):107-118 doi:10.12809/hkmj176336.

    PMID: 29632273
  10. 10

    Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia.

    King AJ, Higgs DR

    Hematology. American Society of Hematology. Education Program 2018; (2018(1)):353-360 doi:10.1182/asheducation-2018.1.353.

    PMID: 30504332
  11. 11

    Characterization of Hb Bart's Hydrops Fetalis Caused by - -SEA and a Large Novel α0-Thalassemia Deletion.

    He S, Li J, Huang P, et al.

    Hemoglobin 2018; (42(1)):61-64 doi:10.1080/03630269.2018.1434198.

    PMID: 29493331
  12. 12

    A Rare Case of Hemoglobin Bart's Hydrops Fetalis due to Uniparental Disomy of Chromosome 16.

    Tan YR, Tan HK

    Journal of medical cases 2021; (12(7)):275-279 doi:10.14740/jmc3693.

    PMID: 34434471
  13. 13

    Clinical Features and Genotypes of Patients with Hemoglobin H Disease in Taiwan.

    Lin PC, Chang TT, Liao YM, et al.

    Laboratory medicine 2019; (50(2)):168-173 doi:10.1093/labmed/lmy043.

    PMID: 30295867
  14. 14

    Anemia among Medical Students from Jakarta: Indonesia-Iron Deficiency or Carrier Thalassemia?

    Wratsangka R, Tungka EX, Murthi AK, et al.

    Anemia 2024; (2024()):4215439 doi:10.1155/2024/4215439.

    PMID: 38716362

This page explains alpha-thalassemia genetics and subtypes for educational purposes. Always consult a hematologist or genetic counselor to interpret your specific DNA testing results and family planning risks.

Stay up to date

Get notified when new research about Alpha-thalassemia is published.

No spam. Unsubscribe anytime.